Showing results (261-270 of 358) with videos related to
Sort By:
Pageof 36
Cancer Research|November 11, 2018
Treatment-Induced Tumor Cell Apoptosis and Secondary Necrosis Drive Tumor Progression in the Residual Tumor Microenvironment through MerTK and IDO1Thomas A Werfel, David L Elion, Bushra Rahman, et al.Cancer Research|December 7, 2014
Kinome-wide functional screen identifies role of PLK1 in hormone-independent, ER-positive breast cancerNeil E Bhola, Valerie M Jansen, Sangeeta Bafna, et al.The Journal of Clinical Investigation|September 25, 2014
Efferocytosis produces a prometastatic landscape during postpartum mammary gland involutionJamie C Stanford, Christian Young, Donna Hicks, et al.Scientific Reports|May 10, 2017
In silico evaluation of DNA Damage Inducible Transcript 4 gene (DDIT4) as prognostic biomarker in several malignanciesJoseph A Pinto, Christian Rolfo, Luis E Raez, et al.Nature Communications|January 18, 2018
DNA methyltransferase inhibition upregulates MHC-I to potentiate cytotoxic T lymphocyte responses in breast cancerNa Luo, Mellissa J Nixon, Paula I Gonzalez-Ericsson, et al.Breast Cancer Research : BCR|August 9, 2014
PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitorsBrian D Lehmann, Joshua A Bauer, Johanna M Schafer, et al.Oncoimmunology|March 17, 2023
Rare immune-related adverse events in patients with melanoma: incidence, spectrum, and clinical presentationsBenjamin C Park, Sathya Narayanan, Alexander Gavraldis, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2021
Tumor-Specific Major Histocompatibility-II Expression Predicts Benefit to Anti-PD-1/L1 Therapy in Patients With HER2-Negative Primary Breast CancerPaula I Gonzalez-Ericsson, Julia D Wulfkhule, Rosa I Gallagher, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2013
Lactate dehydrogenase B: a metabolic marker of response to neoadjuvant chemotherapy in breast cancerJennifer B Dennison, Jennifer R Molina, Shreya Mitra, et al.Journal for Immunotherapy of Cancer|December 10, 2025
Monitoring systemic immune responses to checkpoint inhibition in breast cancer reveals host responses and mechanisms of resistanceAnn Hanna, Xiaopeng Sun, Quanhu Sheng, et al.Pageof 36